Wagner Wealth Management, LLC Biogen Inc. Transaction History

Wagner Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $6,001 - $7,136	32 New	32 $7,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $7,169 - $9,033	-37 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $21,224 - $27,678	-75 Reduced 66.96%	37 $10,000
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $27,713 - $44,373	107 Added 2140.0%	112 $39,000
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $1,214 - $1,423	5 New	5 $1,000
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $5,906 - $8,890	-25 Closed	0 $0
Q2 2018 Aug 01, 2018	BUY	$257.52 - $306.91 $6,438 - $7,672	25 New	25 $7,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Wagner Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wagner Wealth Management, LLC with notifications on news.